MILLENNIUM MANAGEMENT LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1273087
NEW YORK, NY
Position in RXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,733,576
-$1,286,114 QoQ
Shares Held
1,834,762
-29.8% QoQ
Ownership
0.343%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 344 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Sep 30, 2024CallValue
$208,903
CallShares
31,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. RXRX ranks #147 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | 1,491,404 | $197,954,052 | |||
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in RXRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,733,576 | 1,834,762 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,019,690 | 2,612,277 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,117,981 | 1,495,839 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $3,741,404 | 739,408 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,656,151 | 502,108 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $191,375 | 28,310 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $208,903 | 31,700 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $255,579 | 38,783 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $750,000 | 100,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $411,761 | 41,300 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $110,437 | 11,077 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $5,036,415 | 658,355 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $4,312,888 | 646,610 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,361,325 | 695,373 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,547,173 | 239,396 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,119,036 | 383,174 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,545,288 | 495,152 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $579,490 | 33,829 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $1,027,800 | 60,000 | Call | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||